RE: RE: Kedrion Deal...
Cascade can remove Albumin already though a patented process, although interestingly it doesnt have much of a yield advantage over the Cohn process. That's why its particularly relevant to add the prion removal element as a differentiator for the smaller fractionators to compete on Albumin products with the Baxters of the world AND be able to charge a premium ! This, sin itself , will ultimately give the big boyz cause to start using PLI's prion reduction... or even Cascade at some point.
Of course, Cascades real claim to fame is its ability to garner higher yeilds than COHN on other Plasma components such as IVIG and Factor 8.... In addition to higher yields, Cascade also is capable of removing other valuable compounds that the Cohn process cannot remove at all.
Very smart moves by Kedrion, at the same time strengthening PLI's prion removal and the Cascade process' standing in the world Plasma business, and leading to healthy recurring revenues for Prometic.
Going to be very interesting to see what the Kedrion deal expansion is all about